v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Summary of Antidilutive Securities Excluded from Computation of Diluted Net Loss per Share

The following potentially dilutive shares of common stock have not been included in the computation of diluted net loss per share for the three months ended March 31, 2026 and 2025, as the result would be anti-dilutive:

 

Three Months Ended March 31,

 

 

2026

 

 

2025

 

Outstanding stock options

 

3,519,408

 

 

 

3,542,328

 

Outstanding restricted stock units

 

3,732,599

 

 

 

3,428,750

 

Warrants to purchase common stock associated with the April 2022 public offering

 

15,000,000

 

 

 

15,000,000

 

Warrants to purchase common stock associated with the March 2026 Private Placement

 

43,500,000

 

 

 

 

Warrants to purchase common stock associated with loan agreement

 

198,811

 

 

 

198,811

 

Warrants to purchase common stock associated with Danforth

 

50,000

 

 

 

50,000

 

Total

 

66,000,818

 

 

 

22,219,889